To address legal ambiguities, the Office of Artificial Intelligence Policy requires a special malpractice insurance covering AI-generated prescriptions and builds specific duty of care provisions into contracts.

Overview Debates Related claims Topics Sources

Inquiry chair Kate Lampard is considering issuing interim regulations and recommendations regarding Oxevision camera technology to prevent further avoidable patient deaths.

Lawyers representing over 70 bereaved families urged the Lampard Inquiry on October 20, 2026 to recommend a national ban on Oxevision in NHS mental health inpatient wards.

NHS England stated that legal and operational responsibility for deploying and operating the Oxevision camera system rests entirely with individual NHS foundation trusts.

India's Ministry of Health launched the Strategy for Artificial Intelligence in Healthcare for India in February 2026 to govern data, validation, deployment, and monitoring.

EHR vendors should be required to provide open access to third-party AI tools

Big tech's involvement in public scientific research does more harm than good

Public-private partnerships are the most effective way to build foundational scientific datasets

The US government's $500 million investment in AI biological modeling is justified

The Utah Medical Licensing Board previously issued an open letter opposing an earlier pilot by Doctronic, stating they were not consulted and that the program placed citizens at risk.

Utah's Artificial Intelligence Learning Laboratory, or AI sandbox, was established by state law in 2024 to allow the Office of Artificial Intelligence Policy to waive regulations for testing AI products.

The Nolla Health pilot was amended to include a third-party physician appointed by the Utah Medical Licensing Board to oversee prescription reviews.

Utah's Office of Artificial Intelligence Policy approved a plan on October 5, 2026, allowing an artificial intelligence product to evaluate patients and write new drug prescriptions without direct human oversight.

The Utah Office of Artificial Intelligence Policy approved three new healthcare AI pilots on October 2, 2026, covering acne prescription, chronic condition drug renewals, and virtual pelvic floor therapy.

Stanford University professor Michelle Mello argued in a JAMA Health Forum commentary that Doctronic's contract is legally murky regarding liability for potential AI-based prescribing errors.

Expanding healthcare access justifies the risks of Utah's autonomous AI pilots

Utah's regulatory sandbox is an appropriate way to foster healthcare innovation

The Nolla Health pilot program requires the first 100 AI-generated prescriptions to be independently approved by two licensed physicians before reaching patients.

The Utah Medical Licensing Board formally urged state officials in April 2026 to suspend an earlier AI-prescribing pilot by Doctronic, citing critical safety concerns regarding automated clinical decisions.

Utah approved a pilot program launched by Nolla Health on October 5, 2026, allowing an AI system to issue initial medication prescriptions for acne treatment without a doctor visit.

The Office of Artificial Intelligence Policy signed master agreements in September 2026 with University of Utah Health and Intermountain Health to set terms for potential future AI pilots.